SCHEMBL4678280

SCHEMBL4678280

O=C(OCc1ccc(F)cc1Cl)N1CCNCC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
ALOX15 P16050 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
HSD17B10 Q99714 1/20 0.47
GRIN2B Q13224 1/20 0.47
HTT P42858 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
POLB P06746 1/20 0.46
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
MAPT P10636 2/20 0.43
KDM4E B2RXH2 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
HPGD P15428 1/20 0.43
MAPK1 P28482 1/20 0.43
CYP2C19 P33261 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4682111 0.99 GRIN2B (0.47) ALDH1A1L3MBTL1ALOX15NPSR1HSD17B10
SCHEMBL4680752 0.87 ALDH1A1 (0.53) ALDH1A1GRIN2BMAPTHTR2CHTR2B
SCHEMBL543644 0.87 ENPP2 (0.53) L3MBTL1HTTSMN1; SMN2MEN1KMT2A
Hydrochloric Acid SCHEMBL4680744 0.86 ALDH1A1 (0.52) ALDH1A1GRIN2BMAPTHTR2CHTR2B
Hydrochloric Acid SCHEMBL4684572 0.86 ENPP2 (0.53) L3MBTL1HTTSMN1; SMN2MEN1KMT2A
SCHEMBL4678011 0.82 IDO1 (0.48) ALDH1A1
SCHEMBL543229 0.82 HTR2C (0.52) ALDH1A1MEN1KMT2AMAPTENPP2
Hydrochloric Acid SCHEMBL4678004 0.81 IDO1 (0.49) ALDH1A1
SCHEMBL542695 0.81 ALDH1A1 (0.54) ALDH1A1L3MBTL1NPSR1GRIN2BSMN1; SMN2
Hydrochloric Acid SCHEMBL4682149 0.81 HTR2C (0.51) ALDH1A1MEN1KMT2AMAPTENPP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1343775-B1 PIPERAZINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-06-04 EP disclosed
CN-1277824-C Piperazine derivatives HOFFMANN LA ROCHE (CH) 2006-10-04 CN disclosed
US-7022707-B2 Piperazine derivatives HOFFMAN-LA ROCHE INC. (US) 2006-04-04 US disclosed
US-20040235859-A1 Novel piperazine derivatives ADAMS DAVID REGINALD (GB) 2004-11-25 US disclosed
CN-1533382-A Piperazine derivatives - 2004-09-29 CN disclosed
EP-1343775-A2 PIPERAZINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2003-09-17 EP disclosed
US-20020143020-A1 Novel piperazine derivatives VERNALIS RESEARCH LIMITED (GB) 2002-10-03 US disclosed
WO-2002048124-A2 PIPERAZINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2002-06-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020143020-A1 Novel piperazine derivatives CYP4B1, UGT1A1, CYP1B1 ALDH1A1 4/4885L3MBTL1 2739/4885ALOX15 2740/4885
US-20040235859-A1 Novel piperazine derivatives CYP4B1, UGT1A1, CYP1B1 ALDH1A1 4/4885L3MBTL1 2739/4885ALOX15 2740/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.